Cargando…
Dupuytren's disease treatment during the second wave of COVID-19 pandemic
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834312/ https://www.ncbi.nlm.nih.gov/pubmed/33390345 http://dx.doi.org/10.1016/j.bjps.2020.12.030 |
| _version_ | 1783642254587461632 |
|---|---|
| author | Cilli, Vitale |
| author_facet | Cilli, Vitale |
| author_sort | Cilli, Vitale |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7834312 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78343122021-01-26 Dupuytren's disease treatment during the second wave of COVID-19 pandemic Cilli, Vitale J Plast Reconstr Aesthet Surg Correspondence and Communications British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. 2021-03 2020-12-24 /pmc/articles/PMC7834312/ /pubmed/33390345 http://dx.doi.org/10.1016/j.bjps.2020.12.030 Text en © 2020 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence and Communications Cilli, Vitale Dupuytren's disease treatment during the second wave of COVID-19 pandemic |
| title | Dupuytren's disease treatment during the second wave of COVID-19 pandemic |
| title_full | Dupuytren's disease treatment during the second wave of COVID-19 pandemic |
| title_fullStr | Dupuytren's disease treatment during the second wave of COVID-19 pandemic |
| title_full_unstemmed | Dupuytren's disease treatment during the second wave of COVID-19 pandemic |
| title_short | Dupuytren's disease treatment during the second wave of COVID-19 pandemic |
| title_sort | dupuytren's disease treatment during the second wave of covid-19 pandemic |
| topic | Correspondence and Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834312/ https://www.ncbi.nlm.nih.gov/pubmed/33390345 http://dx.doi.org/10.1016/j.bjps.2020.12.030 |
| work_keys_str_mv | AT cillivitale dupuytrensdiseasetreatmentduringthesecondwaveofcovid19pandemic |